Boughton B J, Chakraverty R K, Simpson A, Smith N
Department of Haematology, Queen Elizabeth Hospital, Edgbaston, Birmingham.
Clin Lab Haematol. 1990;12(1):17-23. doi: 10.1111/j.1365-2257.1990.tb01105.x.
Anti-Rho(D) immunoglobulin (anti-D) contained more high molecular weight (HMW) IgG polymers than intravenous non-specific immunoglobulin (i.v. Ig). The low-dose anti-D and high-dose i.v. Ig regimens used to treat idiopathic thrombocytopenic purpura (ITP) therefore contained similar total amounts of HMW IgG. In vitro, the HMW IgG polymers were more effective competitive inhibitors of monocyte phagocyte Fc receptors than monomeric IgG. The IgG subclass composition of anti-D and i.v. Ig were both similar to normal human plasma. We conclude that the HMW IgG content but not the IgG subclass composition of anti-D may explain its low-dose therapeutic efficacy in ITP.
抗Rho(D)免疫球蛋白(抗-D)所含的高分子量(HMW)IgG聚合物比静脉注射非特异性免疫球蛋白(静脉注射Ig)更多。因此,用于治疗特发性血小板减少性紫癜(ITP)的低剂量抗-D和高剂量静脉注射Ig方案所含的HMW IgG总量相似。在体外,HMW IgG聚合物比单体IgG更有效地竞争性抑制单核细胞吞噬细胞Fc受体。抗-D和静脉注射Ig的IgG亚类组成均与正常人血浆相似。我们得出结论,抗-D的HMW IgG含量而非IgG亚类组成可能解释了其在ITP中的低剂量治疗效果。